148 related articles for article (PubMed ID: 31891232)
1. TOB1 suppresses proliferation in K-Ras wild-type pancreatic cancer.
Bai Y; Qiao L; Xie N; Li Y; Nie Y; Pan Y; Shi Y; Wang J; Liu N
Cancer Med; 2020 Feb; 9(4):1503-1514. PubMed ID: 31891232
[TBL] [Abstract][Full Text] [Related]
2. Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).
Jiao Y; Sun KK; Zhao L; Xu JY; Wang LL; Fan SJ
Acta Pharmacol Sin; 2012 Feb; 33(2):250-60. PubMed ID: 22158108
[TBL] [Abstract][Full Text] [Related]
3. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract][Full Text] [Related]
4. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
Xie F; Li C; Zhang X; Peng W; Wen T
Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
[TBL] [Abstract][Full Text] [Related]
5. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
Vorvis C; Hatziapostolou M; Mahurkar-Joshi S; Koutsioumpa M; Williams J; Donahue TR; Poultsides GA; Eibl G; Iliopoulos D
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1124-37. PubMed ID: 27151939
[TBL] [Abstract][Full Text] [Related]
7. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
Xu DF; Wang LS; Zhou JH
Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.
Jiang K; Zhi XH; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9890-9899. PubMed ID: 31799657
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells.
Satoh K; Hamada S; Kimura K; Kanno A; Hirota M; Umino J; Fujibuchi W; Masamune A; Tanaka N; Miura K; Egawa S; Motoi F; Unno M; Vonderhaar BK; Shimosegawa T
Am J Pathol; 2008 Apr; 172(4):926-39. PubMed ID: 18349132
[TBL] [Abstract][Full Text] [Related]
11. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
Qiu C; Bu X; Jiang Z
Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
[TBL] [Abstract][Full Text] [Related]
12. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
[TBL] [Abstract][Full Text] [Related]
13. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract][Full Text] [Related]
14. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of cytoplasmic transducer of ErbB2. 1 expression in gastric cancer.
Zhang SQ; Sun KK; Wu XY; Zhong N; Zhao H; Li DC
Mol Med Rep; 2015 Jul; 12(1):1177-82. PubMed ID: 25760308
[TBL] [Abstract][Full Text] [Related]
16. TMEM176A acts as a tumor suppressor gene in pancreatic cancer by inhibiting ERK signaling.
Guo Y; Cao F; Hu S; Liu S; Sun H; Li A; Li F
Discov Med; 2020; 30(161):145-153. PubMed ID: 33593482
[TBL] [Abstract][Full Text] [Related]
17. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CD137 expression through K-Ras signaling in pancreatic cancer cells.
Glorieux C; Huang P
Cancer Commun (Lond); 2019 Jul; 39(1):41. PubMed ID: 31288851
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the N-myc downstream regulated gene 1 is related to enhanced proliferation, invasion and migration of pancreatic cancer.
Cen G; Zhang K; Cao J; Qiu Z
Oncol Rep; 2017 Feb; 37(2):1189-1195. PubMed ID: 28075464
[TBL] [Abstract][Full Text] [Related]
20. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
Chen Z; Ma Y; Pan Y; Zhu H; Yu C; Sun C
Mol Cell Probes; 2018 Aug; 40():19-26. PubMed ID: 29908229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]